Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Non-Inferiority Designed Cardiovascular Trials in Highest-Impact Journals: Main Findings, Methodological Quality and Time Trends.

Bikdeli B, Welsh JW, Akram Y, Punnanithinont N, Lee I, Desai NR, Kaul S, Stone GW, Ross JS, Krumholz HM.

Circulation. 2019 Jun 10. doi: 10.1161/CIRCULATIONAHA.119.040214. [Epub ahead of print]

PMID:
31177811
2.

Treatment Retention and Outcomes with the Adolescent Community Reinforcement Approach in Emerging Adults with Opioid Use.

Welsh JW, Passetti LL, Funk RR, Smith JE, Meyers RJ, Godley MD.

J Psychoactive Drugs. 2019 May 14:1-10. doi: 10.1080/02791072.2019.1613585. [Epub ahead of print]

PMID:
31088277
3.

Impact of Corticosteroid Administration on Outcomes Following Stereotactic Ablative Radiotherapy for Non-small-cell Lung Cancer.

Li H, Verma V, Brooks ED, Feng L, Zhang T, Welsh JW, Lin SH, Gomez D, Gandhi S, Heymach JV, Chang JY.

Clin Lung Cancer. 2019 Jul;20(4):e480-e488. doi: 10.1016/j.cllc.2019.03.001. Epub 2019 Mar 15.

PMID:
31078421
4.

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.

Gomez DR, Tang C, Zhang J, Blumenschein GR Jr, Hernandez M, Lee JJ, Ye R, Palma DA, Louie AV, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Welsh JW, Gibbons DL, Karam JA, Kavanagh BD, Tsao AS, Sepesi B, Swisher SG, Heymach JV.

J Clin Oncol. 2019 Jun 20;37(18):1558-1565. doi: 10.1200/JCO.19.00201. Epub 2019 May 8.

PMID:
31067138
5.

Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab.

Bloom BC, Augustyn A, Pezzi TA, Menon H, Mayo LL, Shah SJ, Schwartz DL, Chmura SJ, Johnson FM, Welsh JW, Chun SG.

Front Oncol. 2019 Apr 5;9:223. doi: 10.3389/fonc.2019.00223. eCollection 2019.

6.

Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.

Nguyen QN, Chun SG, Chow E, Komaki R, Liao Z, Zacharia R, Szeto BK, Welsh JW, Hahn SM, Fuller CD, Moon BS, Bird JE, Satcher R, Lin PP, Jeter M, O'Reilly MS, Lewis VO.

JAMA Oncol. 2019 Apr 25. doi: 10.1001/jamaoncol.2019.0192. [Epub ahead of print]

PMID:
31021390
7.

IDO1 Inhibition Overcomes Radiation-Induced "Rebound Immune Suppression" by Reducing Numbers of IDO1-Expressing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.

Li A, Barsoumian HB, Schoenhals JE, Caetano MS, Wang X, Menon H, Valdecanas DR, Niknam S, Younes AI, Cortez MA, Welsh JW.

Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):903-912. doi: 10.1016/j.ijrobp.2019.03.022. Epub 2019 Mar 21.

PMID:
30905636
8.

Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment.

Menon H, Ramapriyan R, Cushman TR, Verma V, Kim HH, Schoenhals JE, Atalar C, Selek U, Chun SG, Chang JY, Barsoumian HB, Nguyen QN, Altan M, Cortez MA, Hahn SM, Welsh JW.

Front Immunol. 2019 Feb 15;10:193. doi: 10.3389/fimmu.2019.00193. eCollection 2019. Review.

9.

Glycosylation and Antitumor Immunity.

Cadena AP, Cushman TR, Welsh JW.

Int Rev Cell Mol Biol. 2019;343:111-127. doi: 10.1016/bs.ircmb.2018.05.014. Epub 2018 Jul 17.

PMID:
30712671
10.

Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer.

Brooks ED, Sun B, Feng L, Verma V, Zhao L, Gomez DR, Liao Z, Jeter M, O'Reilly M, Welsh JW, Nguyen QN, Erasmus JJ, Eapen G, Ahrar K, Antonoff MB, Hahn SM, Heymach JV, Rice DC, Chang JY.

JAMA Netw Open. 2018 Aug 3;1(4):e181390. doi: 10.1001/jamanetworkopen.2018.1390.

11.

Racial and Insurance-related Disparities in Delivery of Immunotherapy-type Compounds in the United States.

Verma V, Haque W, Cushman TR, Lin C, Simone CB 2nd, Chang JY, McClelland S 3rd, Welsh JW.

J Immunother. 2019 Feb/Mar;42(2):55-64. doi: 10.1097/CJI.0000000000000253.

PMID:
30628924
12.

Outcomes of re-irradiation for brain recurrence after prophylactic or therapeutic whole-brain irradiation for small cell lung Cancer: a retrospective analysis.

Suzuki R, Wei X, Allen PK, Welsh JW, Cox JD, Komaki R, Lin SH.

Radiat Oncol. 2018 Dec 29;13(1):258. doi: 10.1186/s13014-018-1205-9.

13.

Assessing the association between the strength of state policies on school drug prevention and substance use disorders.

Welsh JW, Hou SS, Shentu Y, Lê Cook B.

Subst Use Misuse. 2019;54(5):811-817. doi: 10.1080/10826084.2018.1544644. Epub 2018 Dec 21.

PMID:
30574799
14.

A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors.

Verma V, Sprave T, Haque W, Simone CB 2nd, Chang JY, Welsh JW, Thomas CR Jr.

J Immunother Cancer. 2018 Nov 23;6(1):128. doi: 10.1186/s40425-018-0442-7. Review.

15.

Altered cancer metabolism in mechanisms of immunotherapy resistance.

Ramapriyan R, Caetano MS, Barsoumian HB, Mafra ACP, Zambalde EP, Menon H, Tsouko E, Welsh JW, Cortez MA.

Pharmacol Ther. 2019 Mar;195:162-171. doi: 10.1016/j.pharmthera.2018.11.004. Epub 2018 Nov 12. Review.

PMID:
30439456
16.

Toxicity of radiation and immunotherapy combinations.

Verma V, Cushman TR, Tang C, Welsh JW.

Adv Radiat Oncol. 2018 Oct 23;3(4):506-511. doi: 10.1016/j.adro.2018.08.003. eCollection 2018 Oct-Dec. Review.

17.

Anti-glucocorticoid-induced Tumor Necrosis Factor-Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects.

Schoenhals JE, Cushman TR, Barsoumian HB, Li A, Cadena AP, Niknam S, Younes AI, Caetano MDS, Cortez MA, Welsh JW.

Front Immunol. 2018 Sep 20;9:2170. doi: 10.3389/fimmu.2018.02170. eCollection 2018.

18.

Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.

Suzuki R, Wei X, Allen PK, Welsh JW, Cox JD, Komaki R, Lin SH.

Clin Lung Cancer. 2018 Nov;19(6):e885-e891. doi: 10.1016/j.cllc.2018.08.012. Epub 2018 Aug 22.

PMID:
30197263
19.

Overview of ongoing clinical trials investigating combined radiotherapy and immunotherapy.

Cushman TR, Caetano MS, Welsh JW, Verma V.

Immunotherapy. 2018 Aug;10(10):851-0. doi: 10.2217/imt-2018-0019.

PMID:
30073899
20.

Addictions Training in General Psychiatry Training Programs: Current Gaps and Barriers.

Schwartz AC, Frank A, Welsh JW, Blankenship K, DeJong SM.

Acad Psychiatry. 2018 Oct;42(5):642-647. doi: 10.1007/s40596-018-0950-2. Epub 2018 Aug 2.

PMID:
30073538
21.

Addictions Training in Child and Adolescent Psychiatry Fellowships.

Welsh JW, Schwartz AC, DeJong SM.

Acad Psychiatry. 2019 Feb;43(1):13-17. doi: 10.1007/s40596-018-0959-6. Epub 2018 Jul 31.

PMID:
30066242
22.

Safety of Combined Immunotherapy and Thoracic Radiation Therapy: Analysis of 3 Single-Institutional Phase I/II Trials.

Verma V, Cushman TR, Selek U, Tang C, Welsh JW.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1141-1148. doi: 10.1016/j.ijrobp.2018.04.054. Epub 2018 Apr 27.

PMID:
30012526
23.

Hematologic variables associated with brain failure in patients with small-cell lung cancer.

Suzuki R, Wei X, Allen PK, Welsh JW, Komaki R, Lin SH.

Radiother Oncol. 2018 Sep;128(3):505-512. doi: 10.1016/j.radonc.2018.05.026. Epub 2018 Jun 12.

PMID:
29907337
24.

Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.

Welsh JW, Tretyak V, McHugh RK, Weiss RD, Bogunovic O.

Drug Alcohol Depend. 2018 Aug 1;189:96-107. doi: 10.1016/j.drugalcdep.2018.04.028. Epub 2018 May 31. Review.

PMID:
29906718
25.

Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti-PD1-Resistant Lung Tumor Model.

Niknam S, Barsoumian HB, Schoenhals JE, Jackson HL, Yanamandra N, Caetano MS, Li A, Younes AI, Cadena A, Cushman TR, Chang JY, Nguyen QN, Gomez DR, Diab A, Heymach JV, Hwu P, Cortez MA, Welsh JW.

Clin Cancer Res. 2018 Nov 15;24(22):5735-5743. doi: 10.1158/1078-0432.CCR-17-3279. Epub 2018 May 21.

26.

Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells.

Li A, Barsoumian HB, Schoenhals JE, Cushman TR, Caetano MS, Wang X, Valdecanas DR, Niknam S, Younes AI, Li G, Woodward WA, Cortez MA, Welsh JW.

Cancer Lett. 2018 Sep 1;431:54-63. doi: 10.1016/j.canlet.2018.05.005. Epub 2018 May 8.

PMID:
29746927
27.

Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation Therapy.

Kim CR, Kim B, Ning MS, Reddy JP, Liao Z, Tang C, Welsh JW, Mott FE, Shih YT, Gomez DR.

Clin Lung Cancer. 2018 Jul;19(4):e517-e528. doi: 10.1016/j.cllc.2018.03.012. Epub 2018 Mar 17.

28.

The Opioid Crisis and Schools-A Commentary.

Welsh JW, Tretyak V, Rappaport N.

J Sch Health. 2018 May;88(5):337-340. doi: 10.1111/josh.12617. No abstract available.

PMID:
29609215
29.

Combining radiation plus immunotherapy to improve systemic immune response.

Cushman TR, Gomez D, Kumar R, Likacheva A, Chang JY, Cadena AP, Paris S, Welsh JW.

J Thorac Dis. 2018 Feb;10(Suppl 3):S468-S479. doi: 10.21037/jtd.2018.01.130. Review.

30.

Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations.

Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA.

Genome Res. 2018 Apr;28(4):432-447. doi: 10.1101/gr.225128.117. Epub 2018 Mar 22.

31.

Radiation therapy and immunotherapy: what is the optimal timing or sequencing?

Aliru ML, Schoenhals JE, Venkatesulu BP, Anderson CC, Barsoumian HB, Younes AI, K Mahadevan LS, Soeung M, Aziz KE, Welsh JW, Krishnan S.

Immunotherapy. 2018 Feb 1;10(4):299-316. doi: 10.2217/imt-2017-0082. Review.

32.

Prognostic significance of pretreatment total lymphocyte count and neutrophil-to-lymphocyte ratio in extensive-stage small-cell lung cancer.

Suzuki R, Lin SH, Wei X, Allen PK, Welsh JW, Byers LA, Komaki R.

Radiother Oncol. 2018 Mar;126(3):499-505. doi: 10.1016/j.radonc.2017.12.030. Epub 2018 Feb 2.

33.

Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer.

Tang C, Hobbs B, Amer A, Li X, Behrens C, Canales JR, Cuentas EP, Villalobos P, Fried D, Chang JY, Hong DS, Welsh JW, Sepesi B, Court L, Wistuba II, Koay EJ.

Sci Rep. 2018 Jan 31;8(1):1922. doi: 10.1038/s41598-018-20471-5.

34.

Radiation and Anti-Cancer Vaccines: A Winning Combination.

Cadena A, Cushman TR, Anderson C, Barsoumian HB, Welsh JW, Cortez MA.

Vaccines (Basel). 2018 Jan 30;6(1). pii: E9. doi: 10.3390/vaccines6010009. Review.

35.

Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.

Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SG.

JAMA Oncol. 2018 Aug 1;4(8):e174504. doi: 10.1001/jamaoncol.2017.4504. Epub 2018 Aug 9.

36.

Adherence to Methodological Standards in Research Using the National Inpatient Sample.

Khera R, Angraal S, Couch T, Welsh JW, Nallamothu BK, Girotra S, Chan PS, Krumholz HM.

JAMA. 2017 Nov 28;318(20):2011-2018. doi: 10.1001/jama.2017.17653.

37.

Merits of Data Sharing: The Digitalis Investigation Group Trial.

Angraal S, Ross JS, Dhruva SS, Desai NR, Welsh JW, Krumholz HM.

J Am Coll Cardiol. 2017 Oct 3;70(14):1825-1827. doi: 10.1016/j.jacc.2017.07.786. No abstract available.

38.

Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control.

An Y, Jiang W, Kim BYS, Qian JM, Tang C, Fang P, Logan J, D'Souza NM, Haydu LE, Wang XA, Hess KR, Kluger H, Glitza IC, Mahajan A, Welsh JW, Lin SH, Yu JB, Davies MA, Hwu P, Sulman EP, Brown PD, Chiang VLS, Li J.

Radiother Oncol. 2017 Oct;125(1):80-88. doi: 10.1016/j.radonc.2017.08.009. Epub 2017 Sep 12.

PMID:
28916225
39.

Incidence of Second Malignancy after Successful Treatment of Limited-Stage Small-Cell Lung Cancer and Its Effects on Survival.

Kono M, Allen PK, Lin SH, Wei X, Jeter MD, Welsh JW, Cox JD, Komaki R.

J Thorac Oncol. 2017 Nov;12(11):1696-1703. doi: 10.1016/j.jtho.2017.07.030. Epub 2017 Aug 10.

40.

Adolescent Frequent Heavy Drinking From 1991-2015.

Welsh JW, Knight JR, Hadland SE.

Pediatrics. 2017 Jun;139(6). pii: e20170932. doi: 10.1542/peds.2017-0932. No abstract available.

41.

Uncovering the immune tumor microenvironment in non-small cell lung cancer to understand response rates to checkpoint blockade and radiation.

Schoenhals JE, Seyedin SN, Anderson C, Brooks ED, Li YR, Younes AI, Niknam S, Li A, Barsoumian HB, Cortez MA, Welsh JW.

Transl Lung Cancer Res. 2017 Apr;6(2):148-158. doi: 10.21037/tlcr.2017.03.06. Review.

42.

Optimizing Radiotherapy with Immunotherapeutic Approaches.

Schoenhals JE, Skrepnik T, Selek U, Cortez MA, Li A, Welsh JW.

Adv Exp Med Biol. 2017;995:53-71. doi: 10.1007/978-3-319-53156-4_3. Review.

PMID:
28321812
43.

Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.

Brooks ED, Sun B, Zhao L, Komaki R, Liao Z, Jeter M, Welsh JW, O'Reilly MS, Gomez DR, Hahn SM, Heymach JV, Rice DC, Chang JY.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):900-907. doi: 10.1016/j.ijrobp.2016.12.022. Epub 2016 Dec 21.

44.

Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials.

Logan JK, Tang C, Liao Z, Lee JJ, Heymach JV, Swisher SG, Welsh JW, Zhang J, Lin SH, Gomez DR.

Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):770-777. doi: 10.1016/j.ijrobp.2016.11.035. Epub 2016 Nov 27.

45.

Association Between Substance Use Diagnoses and Psychiatric Disorders in an Adolescent and Young Adult Clinic-Based Population.

Welsh JW, Knight JR, Hou SS, Malowney M, Schram P, Sherritt L, Boyd JW.

J Adolesc Health. 2017 Jun;60(6):648-652. doi: 10.1016/j.jadohealth.2016.12.018. Epub 2017 Feb 12.

PMID:
28202303
46.

Phase I Trial: SABR and Ipilimumab-Response.

Tang C, Welsh JW, Hong D.

Clin Cancer Res. 2017 Jan 1;23(1):321. doi: 10.1158/1078-0432.CCR-16-2621. No abstract available.

47.

Bilateral Upper Extremity Cellulitis From Injecting Crack Cocaine Dissolved in Lemon Juice: A Case Report.

Welsh JW, Rodriguez C, Suzuki J.

Prim Care Companion CNS Disord. 2016 Oct 13;18(5). doi: 10.4088/PCC.16l01933. No abstract available.

48.

Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy.

Wang X, Schoenhals JE, Li A, Valdecanas DR, Ye H, Zang F, Tang C, Tang M, Liu CG, Liu X, Krishnan S, Allison JP, Sharma P, Hwu P, Komaki R, Overwijk WW, Gomez DR, Chang JY, Hahn SM, Cortez MA, Welsh JW.

Cancer Res. 2017 Feb 15;77(4):839-850. doi: 10.1158/0008-5472.CAN-15-3142. Epub 2016 Nov 7.

49.

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells.

Tang C, Welsh JW, de Groot P, Massarelli E, Chang JY, Hess KR, Basu S, Curran MA, Cabanillas ME, Subbiah V, Fu S, Tsimberidou AM, Karp D, Gomez DR, Diab A, Komaki R, Heymach JV, Sharma P, Naing A, Hong DS.

Clin Cancer Res. 2017 Mar 15;23(6):1388-1396. doi: 10.1158/1078-0432.CCR-16-1432. Epub 2016 Sep 20.

50.

Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial.

Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RU.

J Thorac Oncol. 2017 Feb;12(2):375-382. doi: 10.1016/j.jtho.2016.10.013. Epub 2016 Oct 26.

Supplemental Content

Loading ...
Support Center